Literature DB >> 10755818

Kozak sequence polymorphism in the platelet GPIbalpha gene is not associated with risk of myocardial infarction.

S A Croft, K K Hampton, M E Daly, R P Steeds, K S Channer, N J Samani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10755818

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

Authors:  H Douglas; K Michaelides; D A Gorog; E Durante-Mangoni; N Ahmed; G J Davies; E G D Tuddenham
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

Review 2.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

3.  Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men.

Authors:  Minna Pellikka; Lassi Narhi; Markus Perola; Antti Penttila; Pekka J Karhunen; Jussi Mikkelsson
Journal:  J Thromb Thrombolysis       Date:  2007-07-11       Impact factor: 2.300

4.  Platelet glycoproteins and fibrinogen in recovery from idiopathic sudden hearing loss.

Authors:  Daniel Weiss; Bruno Neuner; Kerstin Gorzelniak; Alexis Bremer; Claudia Rudack; Michael Walter
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

5.  Glycoprotein Ibα Kozak polymorphism in patients presenting with early-onset acute coronary syndrome.

Authors:  Ebru Golcuk; Kivanc Yalin; Cansu Selcan Akdeniz; Erhan Teker; Başak Teker; Veysel Sabri Hancer; Ibrahim Altun; Murat Sezer; Reyhan Diz Kucukkaya; Aytac Oncul
Journal:  Arch Med Sci       Date:  2016-10-26       Impact factor: 3.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.